CIK 0001447028
- Non-accelerated filer
- Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980597776
- Phone
- +1 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-12 | Lo Andrew 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2018-01-12 | Roivant Sciences Ltd. 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2018-01-12 | Machado Patrick 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2018-01-12 | VIKING GLOBAL INVESTORS LP 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2018-01-12 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2018-01-12 | QVT Associates GP LLC Director | Purchase · Series A Participating Convertible Preferred Shares | +664,000 | $100.00 | $66.4M | 1,164,000 |
| 2017-10-16 | Dexxon Holdings Ltd. 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | SVF Investments (UK) Ltd 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | Lo Andrew 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | Roivant Sciences Ltd. 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | Machado Patrick 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | VIKING GLOBAL INVESTORS LP 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | VIKING GLOBAL PERFORMANCE LLC 10% owner | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-16 | QVT Associates GP LLC Director | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50.0M | 500,000 |
| 2017-10-03 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $8.00 | $80K | 1,553,403 |
| 2017-08-15 | Sofia Michael J. Chief Scientific Officer | Sale | −10,000 | $3.75 | $38K | 191,412 |
| 2017-08-15 | Sofia Michael J. Chief Scientific Officer | Sale | −20,000 | $3.68 | $74K | 171,412 |
| 2017-06-21 | MANCHESTER KEITH S Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2017-06-21 | Ramaswamy Vivek Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2017-06-21 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 10 of 12 · 239 trades